CONNAUGHTON BERNADETTE received a stock award from HALOZYME THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/7/2026ACC: 0001159036-26-000059
Director
Since Sep 2018
+12.84K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
12.84K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.80K
Price / share
—
Trade value
—
% of position
17.7%
5/5/2026
38.50K→45.29K
Total
Net shares
+6.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | A · Award | +6.80K | — | — | 17.7% | 38.50K | 45.29K |
| Total | +6.80K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
6.04K shares
Shares
+6.04K
Strike price
65.87
Held after
6.04K
Exercisable
—
5/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock6.04K shares | 5/5/2026 | A · Award | +6.04K | 65.87 | — | 6.04K |